Global Blood Therapeutics (United States)
Corporate R&D · South San Francisco, United States · Founded 2011
Website: gbt.com. Corporate R&D in South San Francisco, United States, founded 2011. Profile and ecosystem links on Innovative EcoSystems.
In context
Global Blood Therapeutics (United States) is one of 48 corporate R&D centers in South San Francisco, California listed in the Innovative EcoSystems registry, and one of 10,487 across the United States.
The registry lists 51 innovation ecosystem organizations in South San Francisco, California in all.
Corporate R&D centers are where established companies develop new products and processes, often in partnership with universities and startups.
The United States scores 68.5 out of 100 on the IEPA (2024 edition), ranking 21 of 117 economies.
See the United States on the IEPA ↗
More corporate R&D centers in South San Francisco, California
- Rapt Therapeutics (United States)
South San Francisco - Lyell Immunopharma (United States)
South San Francisco - Nodality (United States)
South San Francisco - Profusa (United States)
South San Francisco - Annexon Biosciences (United States)
South San Francisco - Denali Therapeutics (United States)
South San Francisco - ALX Oncology Inc. (United States)
South San Francisco - Fluidigm (United States)
South San Francisco
Elsewhere in South San Francisco, California
- Kaiser Permanente South San Francisco Medical Center
Health research - Global Solutions for Infectious Diseases
Research organization - Reset Therapeutics
University or research institute
More corporate R&D centers in the United States
- Alsa Corporation (United States)
Los Angeles - Sun Nuclear (United States)
Melbourne - First Light Diagnostics (United States)
Bedford - OsteoVantage (United States)
Fayetteville - Everest Technologies (United States)
Richardson - ImmuVen (United States)
Champaign - FuelCell Energy (United States)
Danbury - Zeteo Tech (United States)
Sykesville